Ramsay Health Care Limited
Ramsay Health Care Limited RMSYF Peers
See (RMSYF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RMSYF | $25.18 | +0.00% | 5.8B | 503.60 | $0.05 | +2.02% |
| FSNUY | $12.31 | +3.23% | 111.1B | 22.42 | $0.55 | +2.24% |
| FSNUF | $46.21 | +0.00% | 26B | 21.00 | $2.20 | +2.28% |
| JDHIF | $6.27 | +0.00% | 20.1B | 34.84 | $0.18 | N/A |
| JDHIY | $5.10 | +0.00% | 16.3B | 28.33 | $0.18 | N/A |
| FMCQF | $53.61 | +0.00% | 15.7B | 21.62 | $2.48 | +3.05% |
| BDUUY | $32.33 | +0.00% | 12.8B | 28.36 | $1.14 | +2.79% |
| IHHHF | $1.19 | +0.00% | 10.5B | 17.00 | $0.07 | +4.88% |
| BDULF | $0.61 | +0.00% | 9.7B | 20.33 | $0.03 | +3.64% |
| BDUUF | $0.59 | +0.00% | 9.4B | 19.67 | $0.03 | +3.76% |
Stock Comparison
RMSYF vs FSNUY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, FSNUY has a market cap of 111.1B. Regarding current trading prices, RMSYF is priced at $25.18, while FSNUY trades at $12.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas FSNUY's P/E ratio is 22.42. In terms of profitability, RMSYF's ROE is +0.18%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, RMSYF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs FSNUF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, FSNUF has a market cap of 26B. Regarding current trading prices, RMSYF is priced at $25.18, while FSNUF trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas FSNUF's P/E ratio is 21.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, RMSYF is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs JDHIF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, JDHIF has a market cap of 20.1B. Regarding current trading prices, RMSYF is priced at $25.18, while JDHIF trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas JDHIF's P/E ratio is 34.84. In terms of profitability, RMSYF's ROE is +0.18%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, RMSYF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs JDHIY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, JDHIY has a market cap of 16.3B. Regarding current trading prices, RMSYF is priced at $25.18, while JDHIY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas JDHIY's P/E ratio is 28.33. In terms of profitability, RMSYF's ROE is +0.18%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, RMSYF is less volatile compared to JDHIY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs FMCQF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, FMCQF has a market cap of 15.7B. Regarding current trading prices, RMSYF is priced at $25.18, while FMCQF trades at $53.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas FMCQF's P/E ratio is 21.62. In terms of profitability, RMSYF's ROE is +0.18%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, RMSYF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BDUUY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, RMSYF is priced at $25.18, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, RMSYF's ROE is +0.18%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, RMSYF is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs IHHHF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, IHHHF has a market cap of 10.5B. Regarding current trading prices, RMSYF is priced at $25.18, while IHHHF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas IHHHF's P/E ratio is 17.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to IHHHF's ROE of +0.08%. Regarding short-term risk, RMSYF is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BDULF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BDULF has a market cap of 9.7B. Regarding current trading prices, RMSYF is priced at $25.18, while BDULF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BDULF's P/E ratio is 20.33. In terms of profitability, RMSYF's ROE is +0.18%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, RMSYF is less volatile compared to BDULF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BDUUF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BDUUF has a market cap of 9.4B. Regarding current trading prices, RMSYF is priced at $25.18, while BDUUF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BDUUF's P/E ratio is 19.67. In terms of profitability, RMSYF's ROE is +0.18%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, RMSYF is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RMYHY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RMYHY has a market cap of 5.8B. Regarding current trading prices, RMSYF is priced at $25.18, while RMYHY trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RMYHY's P/E ratio is 623.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, RMSYF is less volatile compared to RMYHY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ANHGY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, RMSYF is priced at $25.18, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, RMSYF's ROE is +0.18%, compared to ANHGY's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BUHPF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BUHPF has a market cap of 3.4B. Regarding current trading prices, RMSYF is priced at $25.18, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BUHPF's P/E ratio is 17.96. In terms of profitability, RMSYF's ROE is +0.18%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, RMSYF is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BUGDF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BUGDF has a market cap of 3.4B. Regarding current trading prices, RMSYF is priced at $25.18, while BUGDF trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BUGDF's P/E ratio is 16.27. In terms of profitability, RMSYF's ROE is +0.18%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, RMSYF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MCVEF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MCVEF has a market cap of 3B. Regarding current trading prices, RMSYF is priced at $25.18, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MCVEF's P/E ratio is 82.63. In terms of profitability, RMSYF's ROE is +0.18%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, RMSYF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ORPEF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, RMSYF is priced at $25.18, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, RMSYF's ROE is +0.18%, compared to ORPEF's ROE of -0.16%. Regarding short-term risk, RMSYF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MCVEY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MCVEY has a market cap of 2.2B. Regarding current trading prices, RMSYF is priced at $25.18, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, RMSYF's ROE is +0.18%, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, RMSYF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs TTALF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, RMSYF is priced at $25.18, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas TTALF's P/E ratio is 19.33. In terms of profitability, RMSYF's ROE is +0.18%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, RMSYF is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RYHTY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RYHTY has a market cap of 1.4B. Regarding current trading prices, RMSYF is priced at $25.18, while RYHTY trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RYHTY's P/E ratio is -3.85. In terms of profitability, RMSYF's ROE is +0.18%, compared to RYHTY's ROE of -0.02%. Regarding short-term risk, RMSYF is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RAFLF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RAFLF has a market cap of 1.4B. Regarding current trading prices, RMSYF is priced at $25.18, while RAFLF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RAFLF's P/E ratio is 25.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, RMSYF is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs LWSCF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, LWSCF has a market cap of 1.2B. Regarding current trading prices, RMSYF is priced at $25.18, while LWSCF trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas LWSCF's P/E ratio is 44.72. In terms of profitability, RMSYF's ROE is +0.18%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, RMSYF is less volatile compared to LWSCF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RHCGF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RHCGF has a market cap of 1.2B. Regarding current trading prices, RMSYF is priced at $25.18, while RHCGF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RHCGF's P/E ratio is -3.27. In terms of profitability, RMSYF's ROE is +0.18%, compared to RHCGF's ROE of -0.07%. Regarding short-term risk, RMSYF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs LTGHF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, LTGHF has a market cap of 1.1B. Regarding current trading prices, RMSYF is priced at $25.18, while LTGHF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas LTGHF's P/E ratio is -19.69. In terms of profitability, RMSYF's ROE is +0.18%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, RMSYF is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs LTGHY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, LTGHY has a market cap of 1.1B. Regarding current trading prices, RMSYF is priced at $25.18, while LTGHY trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas LTGHY's P/E ratio is -22.13. In terms of profitability, RMSYF's ROE is +0.18%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, RMSYF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RHKJF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, RMSYF is priced at $25.18, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, RMSYF's ROE is +0.18%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, RMSYF is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RKAGY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RKAGY has a market cap of 986.7M. Regarding current trading prices, RMSYF is priced at $25.18, while RKAGY trades at $7.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RKAGY's P/E ratio is 21.06. In terms of profitability, RMSYF's ROE is +0.18%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, RMSYF is less volatile compared to RKAGY. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NWKHY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NWKHY has a market cap of 950.7M. Regarding current trading prices, RMSYF is priced at $25.18, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NWKHY's P/E ratio is 11.64. In terms of profitability, RMSYF's ROE is +0.18%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, RMSYF is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs WHTCF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, WHTCF has a market cap of 870.8M. Regarding current trading prices, RMSYF is priced at $25.18, while WHTCF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas WHTCF's P/E ratio is -43.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, RMSYF is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs EXETF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, EXETF has a market cap of 792.1M. Regarding current trading prices, RMSYF is priced at $25.18, while EXETF trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas EXETF's P/E ratio is 14.77. In terms of profitability, RMSYF's ROE is +0.18%, compared to EXETF's ROE of +0.66%. Regarding short-term risk, RMSYF is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs JXFGF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, JXFGF has a market cap of 755.6M. Regarding current trading prices, RMSYF is priced at $25.18, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, RMSYF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs KDGTF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, RMSYF is priced at $25.18, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, RMSYF's ROE is +0.18%, compared to KDGTF's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs WFHG Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, WFHG has a market cap of 470.6M. Regarding current trading prices, RMSYF is priced at $25.18, while WFHG trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas WFHG's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, RMSYF is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ORRRY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, RMSYF is priced at $25.18, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, RMSYF's ROE is +0.18%, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, RMSYF is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BTMDW Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, RMSYF is priced at $25.18, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, RMSYF's ROE is +0.18%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, RMSYF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs EVGRF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, EVGRF has a market cap of 234.8M. Regarding current trading prices, RMSYF is priced at $25.18, while EVGRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas EVGRF's P/E ratio is -0.03. In terms of profitability, RMSYF's ROE is +0.18%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, RMSYF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MKLNF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, RMSYF is priced at $25.18, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, RMSYF's ROE is +0.18%, compared to MKLNF's ROE of +0.14%. Regarding short-term risk, RMSYF is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MFCSF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MFCSF has a market cap of 197M. Regarding current trading prices, RMSYF is priced at $25.18, while MFCSF trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MFCSF's P/E ratio is 7.23. In terms of profitability, RMSYF's ROE is +0.18%, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, RMSYF is less volatile compared to MFCSF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs COLRF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, COLRF has a market cap of 143.5M. Regarding current trading prices, RMSYF is priced at $25.18, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas COLRF's P/E ratio is -8.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, RMSYF is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs CHHHF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, CHHHF has a market cap of 129.2M. Regarding current trading prices, RMSYF is priced at $25.18, while CHHHF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas CHHHF's P/E ratio is -51.25. In terms of profitability, RMSYF's ROE is +0.18%, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, RMSYF is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs VTIAF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, VTIAF has a market cap of 95.9M. Regarding current trading prices, RMSYF is priced at $25.18, while VTIAF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas VTIAF's P/E ratio is -6.87. In terms of profitability, RMSYF's ROE is +0.18%, compared to VTIAF's ROE of -0.63%. Regarding short-term risk, RMSYF is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MCIOF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, RMSYF is priced at $25.18, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, RMSYF's ROE is +0.18%, compared to MCIOF's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ASSF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, RMSYF is priced at $25.18, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ASSF's P/E ratio is -33.33. In terms of profitability, RMSYF's ROE is +0.18%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, RMSYF is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs KONEF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, KONEF has a market cap of 44.3M. Regarding current trading prices, RMSYF is priced at $25.18, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas KONEF's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, RMSYF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs USNU Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, RMSYF is priced at $25.18, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas USNU's P/E ratio is -9.41. In terms of profitability, RMSYF's ROE is +0.18%, compared to USNU's ROE of -0.62%. Regarding short-term risk, RMSYF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs HQDA Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, RMSYF is priced at $25.18, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas HQDA's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, RMSYF is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NVLPF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NVLPF has a market cap of 17.3M. Regarding current trading prices, RMSYF is priced at $25.18, while NVLPF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NVLPF's P/E ratio is 19.79. In terms of profitability, RMSYF's ROE is +0.18%, compared to NVLPF's ROE of +0.05%. Regarding short-term risk, RMSYF is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs FPCG Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, RMSYF is priced at $25.18, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas FPCG's P/E ratio is 0.09. In terms of profitability, RMSYF's ROE is +0.18%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, RMSYF is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs GBCS Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, GBCS has a market cap of 9.2M. Regarding current trading prices, RMSYF is priced at $25.18, while GBCS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas GBCS's P/E ratio is -4.41. In terms of profitability, RMSYF's ROE is +0.18%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, RMSYF is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NUMIF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NUMIF has a market cap of 8.5M. Regarding current trading prices, RMSYF is priced at $25.18, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NUMIF's P/E ratio is -0.43. In terms of profitability, RMSYF's ROE is +0.18%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, RMSYF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs HLYK Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, HLYK has a market cap of 8M. Regarding current trading prices, RMSYF is priced at $25.18, while HLYK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas HLYK's P/E ratio is -1.41. In terms of profitability, RMSYF's ROE is +0.18%, compared to HLYK's ROE of +2.41%. Regarding short-term risk, RMSYF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RHEP Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RHEP has a market cap of 7.6M. Regarding current trading prices, RMSYF is priced at $25.18, while RHEP trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RHEP's P/E ratio is -1.58. In terms of profitability, RMSYF's ROE is +0.18%, compared to RHEP's ROE of +1.29%. Regarding short-term risk, RMSYF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs XCRT Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, XCRT has a market cap of 7M. Regarding current trading prices, RMSYF is priced at $25.18, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas XCRT's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, RMSYF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BICX Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BICX has a market cap of 6.6M. Regarding current trading prices, RMSYF is priced at $25.18, while BICX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BICX's P/E ratio is -0.94. In terms of profitability, RMSYF's ROE is +0.18%, compared to BICX's ROE of +0.40%. Regarding short-term risk, RMSYF is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs VLXC Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, VLXC has a market cap of 6.3M. Regarding current trading prices, RMSYF is priced at $25.18, while VLXC trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas VLXC's P/E ratio is -8.80. In terms of profitability, RMSYF's ROE is +0.18%, compared to VLXC's ROE of +0.58%. Regarding short-term risk, RMSYF is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs RVLWF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, RVLWF has a market cap of 5.3M. Regarding current trading prices, RMSYF is priced at $25.18, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, RMSYF's ROE is +0.18%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, RMSYF is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs EPWCF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, RMSYF is priced at $25.18, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas EPWCF's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs GRST Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, GRST has a market cap of 2.3M. Regarding current trading prices, RMSYF is priced at $25.18, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas GRST's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to GRST's ROE of +0.30%. Regarding short-term risk, RMSYF is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs TOKIF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, TOKIF has a market cap of 1.8M. Regarding current trading prices, RMSYF is priced at $25.18, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, RMSYF's ROE is +0.18%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, RMSYF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs SMAS Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, RMSYF is priced at $25.18, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas SMAS's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to SMAS's ROE of N/A. Regarding short-term risk, RMSYF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MDGP Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, RMSYF is priced at $25.18, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MDGP's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, RMSYF is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NOVC Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, RMSYF is priced at $25.18, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NOVC's P/E ratio is -0.20. In terms of profitability, RMSYF's ROE is +0.18%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, RMSYF is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs JRSS Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, JRSS has a market cap of 1.1M. Regarding current trading prices, RMSYF is priced at $25.18, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas JRSS's P/E ratio is -0.13. In terms of profitability, RMSYF's ROE is +0.18%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, RMSYF is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs PHMB Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, RMSYF is priced at $25.18, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas PHMB's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to PHMB's ROE of N/A. Regarding short-term risk, RMSYF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs GNOW Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, RMSYF is priced at $25.18, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas GNOW's P/E ratio is -0.01. In terms of profitability, RMSYF's ROE is +0.18%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, RMSYF is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MSITF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, RMSYF is priced at $25.18, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MSITF's P/E ratio is -0.10. In terms of profitability, RMSYF's ROE is +0.18%, compared to MSITF's ROE of N/A. Regarding short-term risk, RMSYF is less volatile compared to MSITF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NXGT Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NXGT has a market cap of 369.9K. Regarding current trading prices, RMSYF is priced at $25.18, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NXGT's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, RMSYF is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs DPAT Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, DPAT has a market cap of 361.2K. Regarding current trading prices, RMSYF is priced at $25.18, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas DPAT's P/E ratio is -1.50. In terms of profitability, RMSYF's ROE is +0.18%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, RMSYF is less volatile compared to DPAT. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ARPC Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, RMSYF is priced at $25.18, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ARPC's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, RMSYF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs JNHMF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, JNHMF has a market cap of 335.6K. Regarding current trading prices, RMSYF is priced at $25.18, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, RMSYF's ROE is +0.18%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, RMSYF is less volatile compared to JNHMF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs FCHS Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, FCHS has a market cap of 296.6K. Regarding current trading prices, RMSYF is priced at $25.18, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas FCHS's P/E ratio is -0.07. In terms of profitability, RMSYF's ROE is +0.18%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, RMSYF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BNYN Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, RMSYF is priced at $25.18, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BNYN's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, RMSYF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs SETO Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, SETO has a market cap of 276.9K. Regarding current trading prices, RMSYF is priced at $25.18, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas SETO's P/E ratio is -2.22. In terms of profitability, RMSYF's ROE is +0.18%, compared to SETO's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to SETO. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs KJFI Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, KJFI has a market cap of 220.6K. Regarding current trading prices, RMSYF is priced at $25.18, while KJFI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas KJFI's P/E ratio is -0.03. In terms of profitability, RMSYF's ROE is +0.18%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to KJFI. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs TPIA Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, RMSYF is priced at $25.18, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas TPIA's P/E ratio is -0.15. In terms of profitability, RMSYF's ROE is +0.18%, compared to TPIA's ROE of +0.60%. Regarding short-term risk, RMSYF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs AMBD Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, RMSYF is priced at $25.18, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas AMBD's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, RMSYF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NMHLY Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, RMSYF is priced at $25.18, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, RMSYF's ROE is +0.18%, compared to NMHLY's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs DRWN Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, RMSYF is priced at $25.18, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas DRWN's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, RMSYF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs HSMD Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, HSMD has a market cap of 19.2K. Regarding current trading prices, RMSYF is priced at $25.18, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas HSMD's P/E ratio is -0.01. In terms of profitability, RMSYF's ROE is +0.18%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, RMSYF is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs SCAL Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, RMSYF is priced at $25.18, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas SCAL's P/E ratio is 0.04. In terms of profitability, RMSYF's ROE is +0.18%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, RMSYF is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs GENN Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, RMSYF is priced at $25.18, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas GENN's P/E ratio is -0.01. In terms of profitability, RMSYF's ROE is +0.18%, compared to GENN's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs CHCR Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, RMSYF is priced at $25.18, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas CHCR's P/E ratio is -0.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to CHCR's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ACGI Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, RMSYF is priced at $25.18, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ACGI's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, RMSYF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs CEVE Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, RMSYF is priced at $25.18, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas CEVE's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, RMSYF is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NAFS Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NAFS has a market cap of 7K. Regarding current trading prices, RMSYF is priced at $25.18, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NAFS's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, RMSYF is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NRTSF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NRTSF has a market cap of 7K. Regarding current trading prices, RMSYF is priced at $25.18, while NRTSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NRTSF's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to NRTSF's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to NRTSF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs PRMD Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, PRMD has a market cap of 5.6K. Regarding current trading prices, RMSYF is priced at $25.18, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas PRMD's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, RMSYF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MSGP Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, RMSYF is priced at $25.18, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MSGP's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, RMSYF is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs ERUC Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, RMSYF is priced at $25.18, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas ERUC's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to ERUC's ROE of N/A. Regarding short-term risk, RMSYF is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs SLHPF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, RMSYF is priced at $25.18, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas SLHPF's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, RMSYF is more volatile compared to SLHPF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs WEQL Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, RMSYF is priced at $25.18, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas WEQL's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, RMSYF is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BBAL Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, RMSYF is priced at $25.18, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BBAL's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, RMSYF is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs CLRD Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, CLRD has a market cap of 2.7K. Regarding current trading prices, RMSYF is priced at $25.18, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas CLRD's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, RMSYF is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs PAOG Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, PAOG has a market cap of 2.5K. Regarding current trading prices, RMSYF is priced at $25.18, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas PAOG's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, RMSYF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs NMMCF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, RMSYF is priced at $25.18, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, RMSYF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs PPRG Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, RMSYF is priced at $25.18, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas PPRG's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, RMSYF is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs OHAQ Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, RMSYF is priced at $25.18, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, RMSYF's ROE is +0.18%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, RMSYF is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs BNKL Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, RMSYF is priced at $25.18, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas BNKL's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, RMSYF is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs MAHN Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, RMSYF is priced at $25.18, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas MAHN's P/E ratio is 0.05. In terms of profitability, RMSYF's ROE is +0.18%, compared to MAHN's ROE of N/A. Regarding short-term risk, RMSYF is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs SLHGF Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, SLHGF has a market cap of 398. Regarding current trading prices, RMSYF is priced at $25.18, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas SLHGF's P/E ratio is N/A. In terms of profitability, RMSYF's ROE is +0.18%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, RMSYF is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.
RMSYF vs LHRP Comparison
RMSYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMSYF stands at 5.8B. In comparison, LHRP has a market cap of 340. Regarding current trading prices, RMSYF is priced at $25.18, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMSYF currently has a P/E ratio of 503.60, whereas LHRP's P/E ratio is 0.00. In terms of profitability, RMSYF's ROE is +0.18%, compared to LHRP's ROE of N/A. Regarding short-term risk, RMSYF is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for RMSYF.